Table 3.
Antimicrobial studies performed with CUR in liposomes and solid lipid nanoparticles (SLN).
| Type of Liposomes or SLN | [CUR] Formulation | Microorganism | Type of Culture |
Antimicrobial Method | Antimicrobial [CUR] | Reference |
|---|---|---|---|---|---|---|
| Lecithin and cholesterol | 0.5 mg/mL | A. sobria, C. violaceum, A. tumefaciens | Planktonic biofilm | MIC, antibiofilm | 420, 400, and 460 μg/mL | [105] |
| PCNL | 60.65 ± 1.68 µg/µL | B. subtilis, K. pneumoniae, C. violaceum, E. coli, M. smegmatis, A. niger, C. albicans, F. oxysporum | Planktonic | Disk diffusion assay | N/R | [106] |
| Phosphocolines | 100:1 M | S. aureus | Planktonic | MIC | 7 μg/mL | [107] |
| PLGA: triglycerides: F68 | 0.8 mg/mL | E. coli, S. typhimurium, P. aeruginosa, S. aureus, B. sonorensis, B. licheniformis | Planktonic | MIC | 75 and 100 μg/mL | [108] |
| Soya lecithin and menthol | 0.5 mg/mL | MRSA | Planktonic Biofilm |
MIC, microscopy, biomass | 10 and 125 µg/mL | [109] |
| CurSLN | 60 mg/500 mg lipid | S. aureus, S. mutans, V. streptococci, L. acidophilus, E. coli, C. albicans | Planktonic | MIC MBC |
0.09375–3 and 1.5–6 mg/mL | [110] |
[CUR]: CUR concentration. N/R: not reported.